Which has higher earnings and valuation, DXCM or MDT?

Medtronic has higher revenue and earnings than DexCom. Medtronic is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DexCom $4.66B 7.33 $836.30M $2.53 35.79 Medtronic $36.36B 3.30 $4.80B $3.73 25.10

Is DXCM or MDT more profitable?

DexCom has a net margin of 20.12% compared to Medtronic's net margin of 13.20%. DexCom's return on equity of 35.94% beat Medtronic's return on equity. Company Net Margins Return on Equity Return on Assets DexCom 20.12% 35.94% 14.75% Medtronic 13.20% 14.51% 7.76%

Does the media favor DXCM or MDT?

In the previous week, Medtronic had 56 more articles in the media than DexCom. MarketBeat recorded 73 mentions for Medtronic and 17 mentions for DexCom. DexCom's average media sentiment score of 1.51 beat Medtronic's score of 1.40 indicating that DexCom is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DexCom 15 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Medtronic 64 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Positive

Does the media refer more to MDT or GEHC?

In the previous week, Medtronic had 59 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 73 mentions for Medtronic and 14 mentions for GE HealthCare Technologies. Medtronic's average media sentiment score of 1.40 beat GE HealthCare Technologies' score of 0.50 indicating that Medtronic is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medtronic 64 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Positive GE HealthCare Technologies 2 Very Positive mention(s) 1 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ISRG or MDT?

In the previous week, Medtronic had 52 more articles in the media than Intuitive Surgical. MarketBeat recorded 73 mentions for Medtronic and 21 mentions for Intuitive Surgical. Medtronic's average media sentiment score of 1.40 beat Intuitive Surgical's score of 0.72 indicating that Medtronic is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intuitive Surgical 11 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive Medtronic 64 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Positive

Does the media prefer MDT or ABT?

In the previous week, Medtronic had 27 more articles in the media than Abbott Laboratories. MarketBeat recorded 73 mentions for Medtronic and 46 mentions for Abbott Laboratories. Medtronic's average media sentiment score of 1.40 beat Abbott Laboratories' score of 1.40 indicating that Medtronic is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medtronic 64 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Positive Abbott Laboratories 38 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor MDT or BSX?

In the previous week, Medtronic had 33 more articles in the media than Boston Scientific. MarketBeat recorded 73 mentions for Medtronic and 40 mentions for Boston Scientific. Boston Scientific's average media sentiment score of 1.44 beat Medtronic's score of 1.40 indicating that Boston Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medtronic 64 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Positive Boston Scientific 36 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Medtronic (MDT) Competitors

$93.62 -0.51 (-0.54%)

As of 11:04 AM Eastern

Compare

MDT vs. DXCM, GEHC, ISRG, ABT, and BSX

Should you buy Medtronic stock or one of its competitors? Medtronic's main competitors and comparable companies include DexCom (DXCM), GE HealthCare Technologies (GEHC), Intuitive Surgical (ISRG), Abbott Laboratories (ABT), and Boston Scientific (BSX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Medtronic compare to DexCom?

DexCom (NASDAQ:DXCM) and Medtronic (NYSE:MDT) are both large-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, media sentiment, valuation and institutional ownership.

DexCom presently has a consensus target price of $88.71, suggesting a potential downside of 2.04%. Medtronic has a consensus target price of $98.83, suggesting a potential upside of 5.57%. Given Medtronic's higher probable upside, analysts plainly believe Medtronic is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DexCom	1 Sell rating(s)	3 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.89
Medtronic	0 Sell rating(s)	9 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.67

DexCom has a beta of 1.41, meaning that its stock price is 41% more volatile than the broader market. Comparatively, Medtronic has a beta of 0.55, meaning that its stock price is 45% less volatile than the broader market.

DexCom has a net margin of 20.12% compared to Medtronic's net margin of 13.20%. DexCom's return on equity of 35.94% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DexCom	20.12%	35.94%	14.75%
Medtronic	13.20%	14.51%	7.76%

Medtronic has higher revenue and earnings than DexCom. Medtronic is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DexCom	$4.66B	7.33	$836.30M	$2.53	35.79
Medtronic	$36.36B	3.30	$4.80B	$3.73	25.10

In the previous week, Medtronic had 56 more articles in the media than DexCom. MarketBeat recorded 73 mentions for Medtronic and 17 mentions for DexCom. DexCom's average media sentiment score of 1.51 beat Medtronic's score of 1.40 indicating that DexCom is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DexCom	15 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Medtronic	64 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive

97.8% of DexCom shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 0.3% of DexCom shares are owned by company insiders. Comparatively, 0.3% of Medtronic shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

DexCom beats Medtronic on 12 of the 17 factors compared between the two stocks.

How does Medtronic compare to GE HealthCare Technologies?

Medtronic (NYSE:MDT) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, earnings, dividends and valuation.

Medtronic pays an annual dividend of $2.88 per share and has a dividend yield of 3.1%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Medtronic pays out 77.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. GE HealthCare Technologies pays out 3.2% of its earnings in the form of a dividend. Medtronic has increased its dividend for 49 consecutive years and GE HealthCare Technologies has increased its dividend for 1 consecutive years. Medtronic is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Medtronic presently has a consensus price target of $98.83, indicating a potential upside of 5.57%. GE HealthCare Technologies has a consensus price target of $77.73, indicating a potential upside of 3.50%. Given Medtronic's stronger consensus rating and higher possible upside, equities analysts plainly believe Medtronic is more favorable than GE HealthCare Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medtronic	0 Sell rating(s)	9 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.67
GE HealthCare Technologies	0 Sell rating(s)	11 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.48

82.1% of Medtronic shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.3% of Medtronic shares are owned by insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Medtronic has a beta of 0.55, indicating that its stock price is 45% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.69, indicating that its stock price is 31% less volatile than the broader market.

Medtronic has a net margin of 13.20% compared to GE HealthCare Technologies' net margin of 9.33%. GE HealthCare Technologies' return on equity of 20.12% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medtronic	13.20%	14.51%	7.76%
GE HealthCare Technologies	9.33%	20.12%	5.74%

Medtronic has higher revenue and earnings than GE HealthCare Technologies. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medtronic	$36.36B	3.30	$4.80B	$3.73	25.10
GE HealthCare Technologies	$20.63B	1.64	$2.08B	$4.36	17.22

In the previous week, Medtronic had 59 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 73 mentions for Medtronic and 14 mentions for GE HealthCare Technologies. Medtronic's average media sentiment score of 1.40 beat GE HealthCare Technologies' score of 0.50 indicating that Medtronic is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medtronic	64 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive
GE HealthCare Technologies	2 Very Positive mention(s)	1 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Medtronic beats GE HealthCare Technologies on 13 of the 18 factors compared between the two stocks.

How does Medtronic compare to Intuitive Surgical?

Intuitive Surgical (NASDAQ:ISRG) and Medtronic (NYSE:MDT) are both large-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends.

Intuitive Surgical presently has a consensus price target of $508.68, indicating a potential upside of 29.84%. Medtronic has a consensus price target of $98.83, indicating a potential upside of 5.57%. Given Intuitive Surgical's stronger consensus rating and higher possible upside, research analysts clearly believe Intuitive Surgical is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intuitive Surgical	1 Sell rating(s)	8 Hold rating(s)	22 Buy rating(s)	0 Strong Buy rating(s)	2.68
Medtronic	0 Sell rating(s)	9 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.67

Medtronic has higher revenue and earnings than Intuitive Surgical. Medtronic is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intuitive Surgical	$10.06B	13.75	$2.86B	$8.73	44.88
Medtronic	$36.36B	3.30	$4.80B	$3.73	25.10

83.6% of Intuitive Surgical shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 0.6% of Intuitive Surgical shares are owned by insiders. Comparatively, 0.3% of Medtronic shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Intuitive Surgical has a beta of 1.46, indicating that its share price is 46% more volatile than the broader market. Comparatively, Medtronic has a beta of 0.55, indicating that its share price is 45% less volatile than the broader market.

Intuitive Surgical has a net margin of 28.45% compared to Medtronic's net margin of 13.20%. Intuitive Surgical's return on equity of 16.91% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intuitive Surgical	28.45%	16.91%	14.83%
Medtronic	13.20%	14.51%	7.76%

In the previous week, Medtronic had 52 more articles in the media than Intuitive Surgical. MarketBeat recorded 73 mentions for Medtronic and 21 mentions for Intuitive Surgical. Medtronic's average media sentiment score of 1.40 beat Intuitive Surgical's score of 0.72 indicating that Medtronic is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Intuitive Surgical	11 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Positive
Medtronic	64 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive

Summary

Intuitive Surgical beats Medtronic on 12 of the 16 factors compared between the two stocks.

How does Medtronic compare to Abbott Laboratories?

Medtronic (NYSE:MDT) and Abbott Laboratories (NYSE:ABT) are both large-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation and profitability.

Abbott Laboratories has higher revenue and earnings than Medtronic. Medtronic is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medtronic	$36.36B	3.30	$4.80B	$3.73	25.10
Abbott Laboratories	$44.33B	4.48	$6.52B	$3.09	37.17

Medtronic has a net margin of 13.20% compared to Abbott Laboratories' net margin of 11.65%. Abbott Laboratories' return on equity of 17.69% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medtronic	13.20%	14.51%	7.76%
Abbott Laboratories	11.65%	17.69%	9.44%

Medtronic pays an annual dividend of $2.88 per share and has a dividend yield of 3.1%. Abbott Laboratories pays an annual dividend of $2.52 per share and has a dividend yield of 2.2%. Medtronic pays out 77.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Abbott Laboratories pays out 81.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Medtronic has increased its dividend for 49 consecutive years and Abbott Laboratories has increased its dividend for 54 consecutive years. Medtronic is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Medtronic had 27 more articles in the media than Abbott Laboratories. MarketBeat recorded 73 mentions for Medtronic and 46 mentions for Abbott Laboratories. Medtronic's average media sentiment score of 1.40 beat Abbott Laboratories' score of 1.40 indicating that Medtronic is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medtronic	64 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive
Abbott Laboratories	38 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Medtronic presently has a consensus target price of $98.83, indicating a potential upside of 5.57%. Abbott Laboratories has a consensus target price of $118.67, indicating a potential upside of 3.33%. Given Medtronic's higher probable upside, analysts clearly believe Medtronic is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medtronic	0 Sell rating(s)	9 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.67
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	20 Buy rating(s)	3 Strong Buy rating(s)	2.96

Medtronic has a beta of 0.55, meaning that its share price is 45% less volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.59, meaning that its share price is 41% less volatile than the broader market.

82.1% of Medtronic shares are owned by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are owned by institutional investors. 0.3% of Medtronic shares are owned by insiders. Comparatively, 0.5% of Abbott Laboratories shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Abbott Laboratories beats Medtronic on 12 of the 20 factors compared between the two stocks.

How does Medtronic compare to Boston Scientific?

Medtronic (NYSE:MDT) and Boston Scientific (NYSE:BSX) are both large-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, media sentiment, institutional ownership, valuation, earnings and analyst recommendations.

Medtronic presently has a consensus price target of $98.83, indicating a potential upside of 5.57%. Boston Scientific has a consensus price target of $71.62, indicating a potential upside of 41.98%. Given Boston Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Boston Scientific is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medtronic	0 Sell rating(s)	9 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.67
Boston Scientific	2 Sell rating(s)	5 Hold rating(s)	24 Buy rating(s)	0 Strong Buy rating(s)	2.71

Boston Scientific has a net margin of 17.50% compared to Medtronic's net margin of 13.20%. Boston Scientific's return on equity of 19.28% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medtronic	13.20%	14.51%	7.76%
Boston Scientific	17.50%	19.28%	10.89%

In the previous week, Medtronic had 33 more articles in the media than Boston Scientific. MarketBeat recorded 73 mentions for Medtronic and 40 mentions for Boston Scientific. Boston Scientific's average media sentiment score of 1.44 beat Medtronic's score of 1.40 indicating that Boston Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medtronic	64 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive
Boston Scientific	36 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Medtronic has higher revenue and earnings than Boston Scientific. Boston Scientific is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medtronic	$36.36B	3.30	$4.80B	$3.73	25.10
Boston Scientific	$21.00B	3.48	$2.90B	$2.47	20.42

82.1% of Medtronic shares are owned by institutional investors. Comparatively, 89.1% of Boston Scientific shares are owned by institutional investors. 0.3% of Medtronic shares are owned by company insiders. Comparatively, 0.3% of Boston Scientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Medtronic has a beta of 0.55, suggesting that its share price is 45% less volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.56, suggesting that its share price is 44% less volatile than the broader market.

Summary

Boston Scientific beats Medtronic on 11 of the 16 factors compared between the two stocks.

Get Medtronic News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MDT vs. The Competition

Export

Metric	Medtronic	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$119.83B	$5.80B	$7.26B	$24.19B
Dividend Yield	3.13%	1.76%	2.55%	3.72%
P/E Ratio	25.10	25.98	269.16	30.11
Price / Sales	3.30	40.97	615.85	19.97
Price / Cash	11.73	33.29	78.23	31.97
Price / Book	2.40	5.97	13.06	6.84
Net Income	$4.80B	$148.28M	$3.46B	$1.07B
7 Day Performance	3.23%	0.48%	1.37%	-0.98%
1 Month Performance	12.41%	5.66%	4.49%	2.54%
1 Year Performance	0.52%	9.58%	27.84%	17.82%

Medtronic Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MDT Medtronic	4.6438 of 5 stars	$93.62 -0.5%	$98.83 +5.6%	+4.7%	$119.83B	$36.36B	25.10	95,000	Positive News Analyst Forecast
DXCM DexCom	4.3312 of 5 stars	$87.65 +3.4%	$88.71 +1.2%	+11.1%	$33.08B	$4.66B	34.64	11,000
GEHC GE HealthCare Technologies	4.161 of 5 stars	$72.94 +1.6%	$77.73 +6.6%	+0.9%	$32.95B	$21.27B	16.73	54,000	Analyst Forecast
ISRG Intuitive Surgical	4.5008 of 5 stars	$393.38 +3.8%	$509.02 +29.4%	-17.0%	$138.97B	$10.06B	45.06	17,021
ABT Abbott Laboratories	4.6035 of 5 stars	$108.65 +0.8%	$118.17 +8.8%	-12.7%	$188.01B	$44.33B	35.16	115,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MDT) was last updated on 8/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Medtronic (MDT) Competitors

MDT vs. DXCM, GEHC, ISRG, ABT, and BSX

How does Medtronic compare to DexCom?

Summary

How does Medtronic compare to GE HealthCare Technologies?

Summary

How does Medtronic compare to Intuitive Surgical?

Summary

How does Medtronic compare to Abbott Laboratories?

Summary

How does Medtronic compare to Boston Scientific?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDT vs. The Competition

Medtronic Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Medtronic (MDT) Competitors

MDT vs. DXCM, GEHC, ISRG, ABT, and BSX

How does Medtronic compare to DexCom?

Do analysts recommend DXCM or MDT?

Which has more risk & volatility, DXCM or MDT?

Is DXCM or MDT more profitable?

Which has higher earnings and valuation, DXCM or MDT?

Does the media favor DXCM or MDT?

Do institutionals and insiders hold more shares of DXCM or MDT?

Summary

How does Medtronic compare to GE HealthCare Technologies?

Is MDT or GEHC a better dividend stock?

Do analysts prefer MDT or GEHC?

Do insiders and institutionals hold more shares of MDT or GEHC?

Which has more volatility and risk, MDT or GEHC?

Is MDT or GEHC more profitable?

Which has better earnings & valuation, MDT or GEHC?

Does the media refer more to MDT or GEHC?

Summary

How does Medtronic compare to Intuitive Surgical?

Do analysts recommend ISRG or MDT?

Which has higher valuation and earnings, ISRG or MDT?

Do institutionals and insiders believe in ISRG or MDT?

Which has more risk & volatility, ISRG or MDT?

Is ISRG or MDT more profitable?

Does the media favor ISRG or MDT?

Summary

How does Medtronic compare to Abbott Laboratories?

Which has stronger valuation and earnings, MDT or ABT?

Is MDT or ABT more profitable?

Is MDT or ABT a better dividend stock?

Does the media prefer MDT or ABT?

Do analysts rate MDT or ABT?

Which has more volatility and risk, MDT or ABT?

Do institutionals and insiders hold more shares of MDT or ABT?

Summary

How does Medtronic compare to Boston Scientific?

Do analysts recommend MDT or BSX?

Is MDT or BSX more profitable?

Does the media favor MDT or BSX?

Which has stronger earnings & valuation, MDT or BSX?

Do insiders and institutionals believe in MDT or BSX?

Which has more risk and volatility, MDT or BSX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDT vs. The Competition

Medtronic Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools